A Phase 1 Open-label, Two-arm,Drug-drug Interaction Study To Evaluate The Effect Of Itraconazole And Rifampin On The Pharmacokinetics Of Talazoparib In Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Talazoparib (Primary) ; Itraconazole; Rifampicin
- Indications Adenocarcinoma; Breast cancer; Cervical cancer; Ovarian cancer; Small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Medivation; Pfizer
- 21 Nov 2017 Planned End Date changed from 23 Dec 2017 to 9 Jan 2018.
- 21 Nov 2017 Planned primary completion date changed from 31 Oct 2017 to 9 Jan 2018.
- 11 Sep 2017 Planned End Date changed from 31 Oct 2017 to 23 Dec 2017.